Patents by Inventor Michael Karas
Michael Karas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150358160Abstract: A method, system and apparatus for deriving a secondary secret from a root secret are described, the method, system and apparatus including reserving a memory buffer included in an integrated circuit, the memory buffer being large enough to contain all of the bits which will include the secondary secret, receiving a plurality of bits from a root secret, the root secret being stored in a secure memory of the integrated circuit, inputting the plurality of bits from the root secret and at least one control bit into a permutation network, and thereby producing a multiplicity of output bits, the at least one control bit including one of one bit of a value g, and one bit an output of a function which receives g as an input, receiving the multiplicity of output bits from the permutation network, inputting the multiplicity of output bits from the permutation network into a plurality of logic gates, thereby combining the multiplicity of output bits, wherein a fixed number of bits is output from the logic gates, inputtType: ApplicationFiled: July 10, 2013Publication date: December 10, 2015Inventors: Michael KARA-IVANOV, Aviad KIPNIS, Tzachy REINMAN, Efraim MANGELL, Erez WAISBARD, Yaacov BELENKY
-
Publication number: 20150280906Abstract: A method for protecting encoded data from algebraic manipulation includes receiving a data word s?Kd to be protected, randomly selecting two integers a?{0, . . . , q?1} and b?{0, . . . , ?q?1}, finding a point (?, ?) on a Hermitian curve over a field Fq that corresponds to the randomly selected integers (a, b) from a mapping (a, b)(?, ?)=(ua, ua?q+1z+vb), where u a := { 0 if ? ? a = 0 , ? 1 a - 1 otherwise , ? ? V b := { 0 if ? ? b = 0 , ? 2 b - 1 otherwise , and z is an element of the field Fq of unit trace, and where ?1 is a fixed primitive element of the field Fq and ?2 is a primitive element of a field F?q?Fq, and calculating a sum fs(?, ?)=?id+1?jd+1+?k=1d?ik?kjk or a set of d+1 integers pairs I={(ik,jk)}k=1d+1, where the encoded word is a triple (s, (?, ?),fs(?, ?)).Type: ApplicationFiled: March 27, 2014Publication date: October 1, 2015Applicant: SAMSUNG ISRAEL RESEARCH CORPORATIONInventors: YARON SHANY, Shay Landis, Elona Erez, Avner Dor, Michael Kara-Ivanov, Moshe Twitto, Jun Jin Kong
-
Patent number: 8980642Abstract: The present invention relates to the use of cyanocinnamic acid derivatives as a matrix in the MALDI mass spectrometry of an analyte.Type: GrantFiled: July 10, 2008Date of Patent: March 17, 2015Assignee: Sigma-Aldrich International GmbHInventors: Michael Karas, Thorsten Wolfgang Jaskolla
-
Publication number: 20130040395Abstract: The present invention relates to the use of a halogenated cyanocinnamic acid derivative with the general formula: wherein R is selected independently among F, Cl and Br, n=3, 4 or 5 and R? is selected among COOH, CONH2, SO3H and COOR? with R?=C1-O5-Alkyl; and/or of 4-bromo-?-cyanocinnamic acid and/or of ?-cyano-2,4-dichlorocinnamic acid in a matrix for a MALDI mass spectrometry of an analyte.Type: ApplicationFiled: March 2, 2011Publication date: February 14, 2013Applicant: JOHANN WOLFGANG GOETHE-UNIVERSITÄTInventors: Thorsten Jaskolla, Michael Karas
-
Patent number: 8131374Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: GrantFiled: August 5, 2011Date of Patent: March 6, 2012Assignee: Encore Medical Asset CorporationInventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Publication number: 20110288616Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: ApplicationFiled: August 5, 2011Publication date: November 24, 2011Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Publication number: 20110288601Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: ApplicationFiled: August 5, 2011Publication date: November 24, 2011Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Patent number: 8019426Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: GrantFiled: July 16, 2007Date of Patent: September 13, 2011Assignee: Encore Medical Asset CorporationInventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Publication number: 20110121166Abstract: The present invention relates to the use of cyanocinnamic acid derivatives as a matrix in the MALDI mass spectrometry of an analyte.Type: ApplicationFiled: July 10, 2008Publication date: May 26, 2011Inventor: Michael Karas
-
Publication number: 20100167410Abstract: The invention relates to a mass spectrometric method for the detection and for the quantification of double stranded nucleic acids which are not covalently associated with one another.Type: ApplicationFiled: December 7, 2007Publication date: July 1, 2010Applicants: BioSpring Gesellschaft für Biotechnologie mbH, Johann Wolfgang Goethe-Universität Frankfurt am MainInventors: Huseyin Aygün, Michael Karas, Ute Bahr
-
Publication number: 20100016392Abstract: In one aspect, this invention relates to a substantially water-insoluble pesticidal aggregate produced from a mixture comprising: (a) a polymer having at least three similarly charged electrostatic moieties; (b) an amphiphilic surfactant having at least one electrostatically charged moiety of opposite charge to the polymer; and (c) a pesticide. In other aspects, this invention relates pesticidal compositions comprising such a pesticidal aggregate and an agriculturally acceptable carrier, as well as to a method of controlling pests using such pesticidal compositions.Type: ApplicationFiled: December 13, 2007Publication date: January 21, 2010Applicant: Innovaform Technologies, LLCInventors: Alexander V. Kabanov, Michael Karas, Tatiana K. Bronitch, Robin Dexter
-
Publication number: 20090306003Abstract: An improved pesticide delivery system is disclosed. The system is based on a microblend comprising (a) an amphophilic compound containing at least one hydrophilic group and at least one hydrophobic group and (b) a second compound. Compositions based on the microblend and methods of using the compositions to control pests are also disclosed.Type: ApplicationFiled: January 10, 2007Publication date: December 10, 2009Applicant: Innovation Technologies, LLCInventors: Alexander V. Kabanov, Tatiana K. Bronitch, Michael Karas, Bruce L. Frank
-
Publication number: 20090137667Abstract: An improved pesticide delivery system is disclosed. The system is based on a microblend comprising (a) an amphiphilic compound containing at least one hydrophilic group and at least one hydrophobic group and (b) a pesticide. Compositions based on the microblend and methods of using the compositions to control pests are also disclosed.Type: ApplicationFiled: January 10, 2007Publication date: May 28, 2009Applicant: Innovaform Technologies, LLCInventors: Alexander V. Kabanov, Tatiana K. Bronitch, Michael Karas
-
Publication number: 20090081791Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.Type: ApplicationFiled: June 24, 2008Publication date: March 26, 2009Applicant: Lonza Walkersville, Inc.Inventor: Michael Karas
-
Patent number: 7420031Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.Type: GrantFiled: December 28, 2005Date of Patent: September 2, 2008Assignee: Lonza Walkersville, Inc.Inventor: Michael Karas
-
Publication number: 20080114414Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: ApplicationFiled: July 16, 2007Publication date: May 15, 2008Inventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Patent number: 7254444Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: GrantFiled: October 17, 2002Date of Patent: August 7, 2007Assignee: Encore Medical Asset CorporationInventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Patent number: 7166692Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.Type: GrantFiled: March 3, 2004Date of Patent: January 23, 2007Assignee: Canbrex Bio Science Walkersville, Inc.Inventor: Michael Karas
-
Publication number: 20060106197Abstract: An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.Type: ApplicationFiled: December 28, 2005Publication date: May 18, 2006Inventor: Michael Karas
-
Patent number: 7015462Abstract: A process for separation of components of a sample in an ion mobility spectrometer using a supply of selectively interactive gaseous particles. The components to be separated carry out selective interaction processes in a drift tube of the ion mobility spectrometer with specifically selected particles, in particular enantiometric collision molecules, which are supplied to a gas inlet, in such a way that they exhibit different rates of mobility during their drift from a sample inlet through the drift tube to an ion collector. This enables the ions to be detected in the ion collector in a time-delayed manner.Type: GrantFiled: May 28, 2002Date of Patent: March 21, 2006Inventor: Michael Karas